Aktie 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Aktien

002864

CNE1000032C9

002864

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
29.57 CNY -1.60% Intraday Chart für Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -2.22% -23.17%
26.04. Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. schlägt letzte Bardividende für das Jahr 2023 vor CI
25.04. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd berichtet über die Ergebnisse für das Geschäftsjahr zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.
Panlong Pharmaceutical Plans 20 Million Yuan Share Buyback
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announces an Equity Buyback for CNY 20 million worth of its shares.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd authorizes a Buyback Plan.
Panlong Pharmaceutical Gets Sanitary License
Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Panlong Pharma Completes Registration of New Medical Clinic
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Approves Cash Dividend for 2022, Payable on May 31, 2023
Chinese Shares Retreat; Panlong Pharma Falls 7% on 302 Million Yuan Share Sale
Shaanxi Panlong Pharma Selling 302 Million Yuan Shares to Fund New Projects
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Proposes Final Cash Dividend for 2022
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Panlong Pharma Gets US Patent for Coronavirus Protease Inhibitor
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002864 Aktie
  4. Nachrichten Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
  5. Andere Sprachen